{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:02:07Z","timestamp":1790114527950,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11686-025-00994-4","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T14:09:06Z","timestamp":1738937346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the Anti-Leishmanial Activity of the Hydroalcoholic Extract of Green Algae (Spirogyra): Investigation of Weight Indicators (Lesion Size and Organ Weights) in BALB\/c Mice"],"prefix":"10.1007","volume":"70","author":[{"given":"Rahmatollah","family":"Zarezadeh Mehrizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Fattahi","family":"Bafghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Sarafraz Ardakani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen Nabi","family":"Meybodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Zare-Zardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"issue":"1","key":"994_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","volume":"10","author":"D Steverding","year":"2017","unstructured":"Steverding D (2017) The history of leishmaniasis. Parasites Vectors 10(1):82","journal-title":"Parasites Vectors"},{"issue":"2","key":"994_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4103\/0974-777X.62881","volume":"2","author":"L Kedzierski","year":"2010","unstructured":"Kedzierski L (2010) Leishmaniasis Vaccine: where are we today? J Global Infect Dis 2(2):177\u2013185","journal-title":"J Global Infect Dis"},{"issue":"12","key":"994_CR3","doi-asserted-by":"publisher","first-page":"e1032","DOI":"10.1016\/j.ijid.2010.06.019","volume":"14","author":"A Pavli","year":"2010","unstructured":"Pavli A, Maltezou HC (2010) Leishmaniasis, an emerging infection in travelers. Int J Infect Dis 14(12):e1032\u2013e9","journal-title":"Int J Infect Dis"},{"key":"994_CR4","doi-asserted-by":"publisher","first-page":"1052478","DOI":"10.3389\/fmicb.2022.1052478","volume":"13","author":"CA Knight","year":"2022","unstructured":"Knight CA, Harris DR, Alshammari SO, Gugssa A, Young T, Lee CM (2022) Leishmaniasis: recent epidemiological studies in the Middle East. Front Microbiol 13:1052478","journal-title":"Front Microbiol"},{"issue":"5","key":"994_CR5","doi-asserted-by":"publisher","first-page":"e0285663","DOI":"10.1371\/journal.pone.0285663","volume":"18","author":"H Nuwangi","year":"2023","unstructured":"Nuwangi H, Agampodi TC, Price HP, Shepherd T, Weerakoon KG, Agampodi SB (2023) The stigma associated with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL): a protocol for a systematic review. PLoS ONE 18(5):e0285663","journal-title":"PLoS ONE"},{"issue":"6","key":"994_CR6","first-page":"763","volume":"22","author":"T Fischer","year":"2024","unstructured":"Fischer T, Fischer M, Schliemann S, Elsner P (2024) Treatment of mucocutaneous leishmaniasis\u2013a systematic review. JDDG: J Der Deutschen Dermatologischen Gesellschaft 22(6):763\u2013773","journal-title":"JDDG: J Der Deutschen Dermatologischen Gesellschaft"},{"issue":"4","key":"994_CR7","first-page":"236","volume":"65","author":"H Ghafoori","year":"2020","unstructured":"Ghafoori H, Sandoughsaz RS, Mirzaei F, Zare-Zardini H, Soltaninejad H (2020) Investigation of the Antileishmanial Activity of Medica Gosativa Extract: an in vitro study. Okiwbio\u00e7-\u2206\u03b5k\u03b5\u00b5\u03b2si\u00e7 65(4):236\u2013243","journal-title":"Okiwbio\u00e7-\u2206\u03b5k\u03b5\u00b5\u03b2si\u00e7"},{"key":"994_CR8","doi-asserted-by":"publisher","first-page":"571242","DOI":"10.4061\/2011\/571242","volume":"2011","author":"AK Haldar","year":"2011","unstructured":"Haldar AK, Sen P, Roy S (2011) Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biology Int 2011:571242","journal-title":"Mol Biology Int"},{"issue":"9","key":"994_CR9","first-page":"e0009734","volume":"15","author":"C Oliveira-Ribeiro","year":"2021","unstructured":"Oliveira-Ribeiro C, Pimentel MIF (2021) An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center. Rio De Janeiro Brazil 15(9):e0009734","journal-title":"Rio De Janeiro Brazil"},{"issue":"5","key":"994_CR10","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jiph.2024.03.008","volume":"17","author":"AI Pinto","year":"2024","unstructured":"Pinto AI, Caldas C, Santar\u00e9m N, Luelmo S, Costa I, Martins C et al (2024) Leishmania and HIV co-infection: first naturally Leishmania strain presenting decreased susceptibility to miltefosine, recovered from a patient in Portugal. J Infect Public Health 17(5):810\u2013818","journal-title":"J Infect Public Health"},{"key":"994_CR11","doi-asserted-by":"crossref","unstructured":"Hong A, Zampieri RA, Shaw JJ, Floeter-Winter LM, Laranjeira-Silva MF (2020) One Health Approach to leishmaniases: understanding the Disease dynamics through Diagnostic tools. Pathogens 9(10)","DOI":"10.3390\/pathogens9100809"},{"key":"994_CR12","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1016\/j.vaccine.2023.01.057","volume":"41","author":"PM Kaye","year":"2023","unstructured":"Kaye PM, Matlashewski G, Mohan S, Le Rutte E, Mondal D, Khamesipour A et al (2023) Vaccine value profile for leishmaniasis. Vaccine 41:S153\u2013S75","journal-title":"Vaccine"},{"issue":"10","key":"994_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apjtm.2016.06.021","volume":"9","author":"A Oryan","year":"2016","unstructured":"Oryan A, Akbari M (2016) Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med 9(10):925\u2013932","journal-title":"Asian Pac J Trop Med"},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"1091709","DOI":"10.3389\/fpubh.2023.1091709","volume":"11","author":"I Sharifi","year":"2023","unstructured":"Sharifi I, Khosravi A, Aflatoonian MR, Salarkia E, Bamorovat M, Karamoozian A et al (2023) Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan. Front Public Health 11:1091709","journal-title":"Front Public Health"},{"issue":"1","key":"994_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s44197-024-00190-z","volume":"14","author":"M Bamorovat","year":"2024","unstructured":"Bamorovat M, Sharifi I, Khosravi A, Aflatoonian MR, Agha Kuchak Afshari S, Salarkia E et al (2024) Global dilemma and needs Assessment toward Achieving Sustainable Development Goals in Controlling Leishmaniasis. J Epidemiol Glob Health 14(1):22\u201334","journal-title":"J Epidemiol Glob Health"},{"issue":"11","key":"994_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/tropicalmed9110258","volume":"9","author":"C Cosma","year":"2024","unstructured":"Cosma C, Maia C, Khan N, Infantino M, Del Riccio M (2024) Leishmaniasis in humans and animals: a One Health Approach for Surveillance, Prevention and Control in a changing World. Trop Med Infect Disease 9(11):258","journal-title":"Trop Med Infect Disease"},{"issue":"3","key":"994_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","volume":"10","author":"J van Griensven","year":"2010","unstructured":"van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M (2010) Combination therapy for visceral leishmaniasis. Lancet Infect Dis 10(3):184\u2013194","journal-title":"Lancet Infect Dis"},{"key":"994_CR18","unstructured":"Taheri AR, Rad SS, Molkara S (2019) Systemic treatments of Leishmaniasis: a narrative review. Reviews Clin Med 6(3)"},{"issue":"3","key":"994_CR19","first-page":"295","volume":"63","author":"HMMF Al","year":"2020","unstructured":"Al HMMF, Ali HZ, Hassan GM, Ghaffarifar F (2020) Artemisinin efficacy against old world leishmania donovani: in vitro and ex vivo study. Ann Parasitol 63(3):295\u2013302","journal-title":"Ann Parasitol"},{"issue":"1","key":"994_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/AAC.01499-13","volume":"58","author":"KC Kato","year":"2014","unstructured":"Kato KC, Morais-Teixeira E, Reis PG, Silva-Barcellos NM, Sala\u00fcn P, Campos PP et al (2014) Hepatotoxicity of pentavalent antimonial drug: possible role of residual sb(III) and protective effect of ascorbic acid. Antimicrob Agents Chemother 58(1):481\u2013488","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"994_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","volume":"26","author":"R Laniado-Labor\u00edn","year":"2009","unstructured":"Laniado-Labor\u00edn R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Revista Iberoamericana De micolog\u00eda 26(4):223\u2013227","journal-title":"Revista Iberoamericana De micolog\u00eda"},{"issue":"12","key":"994_CR22","doi-asserted-by":"publisher","first-page":"e0315710","DOI":"10.1371\/journal.pone.0315710","volume":"19","author":"LR Ribeiro","year":"2024","unstructured":"Ribeiro LR, Silva SN, Saliba MF, de Pina Carvalho J, Cota G (2024) Safety profile of miltefosine in the treatment of cutaneous leishmaniasis. PLoS ONE 19(12):e0315710","journal-title":"PLoS ONE"},{"key":"994_CR23","doi-asserted-by":"crossref","unstructured":"Fu X, Wan P, Li P, Wang J, Guo S, Zhang Y et al (2021) Mechanism and Prevention of Ototoxicity Induced by aminoglycosides. Front Cell Neurosci 15","DOI":"10.3389\/fncel.2021.692762"},{"issue":"2","key":"994_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/0974-777X.62887","volume":"2","author":"J Chakravarty","year":"2010","unstructured":"Chakravarty J, Sundar S (2010) Drug resistance in leishmaniasis. J Glob Infect Dis 2(2):167\u2013176","journal-title":"J Glob Infect Dis"},{"key":"994_CR25","doi-asserted-by":"crossref","unstructured":"Wijnant G-J, Dumetz F, Dirkx L, Bult\u00e9 D, Cuypers B, Van Bocxlaer K et al (2022) Tackling Drug Resistance and other causes of treatment failure in Leishmaniasis. Front Trop Dis 3","DOI":"10.3389\/fitd.2022.837460"},{"issue":"1","key":"994_CR26","doi-asserted-by":"publisher","first-page":"e0012735","DOI":"10.1371\/journal.pntd.0012735","volume":"19","author":"H Zhang","year":"2025","unstructured":"Zhang H, Yan R, Liu Y, Yu M, He Z, Xiao J et al (2025) Progress in antileishmanial drugs: mechanisms, challenges, and prospects. PLoS Negl Trop Dis 19(1):e0012735","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"994_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/00001432-200212000-00007","volume":"15","author":"S Sundar","year":"2002","unstructured":"Sundar S, Rai M (2002) Advances in the treatment of leishmaniasis. Curr Opin Infect Dis 15(6):593\u2013598","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"994_CR28","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/microorganisms9122500","volume":"9","author":"AI Ol\u00edas-Molero","year":"2021","unstructured":"Ol\u00edas-Molero AI, de la Fuente C, Cuquerella M, Torrado JJ, Alunda JM (2021) Antileishmanial Drug Discovery and Development: time to Reset the Model? Microorganisms 9(12):2500","journal-title":"Microorganisms"},{"key":"994_CR29","doi-asserted-by":"publisher","first-page":"115609","DOI":"10.1016\/j.ejmech.2023.115609","volume":"258","author":"R Pal","year":"2023","unstructured":"Pal R, Teli G, Akhtar MJ, Matada GSP (2023) The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis. Eur J Med Chem 258:115609","journal-title":"Eur J Med Chem"},{"key":"994_CR30","doi-asserted-by":"publisher","first-page":"108554","DOI":"10.1016\/j.exppara.2023.108554","volume":"251","author":"RC Afonso","year":"2023","unstructured":"Afonso RC, Yien RMK, de Siqueira LBO, Simas NK, dos Santos Matos AP, Ricci-J\u00fanior E (2023) Promising natural products for the treatment of cutaneous leishmaniasis: a review of in vitro and in vivo studies. Exp Parasitol 251:108554","journal-title":"Exp Parasitol"},{"key":"994_CR31","doi-asserted-by":"crossref","unstructured":"Nieri P, Carpi S, Esposito R, Costantini M, Zupo V (2023) Bioactive molecules from Marine diatoms and their value for the Nutraceutical Industry. Nutrients 15(2)","DOI":"10.3390\/nu15020464"},{"issue":"6","key":"994_CR32","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3390\/life13061411","volume":"13","author":"RMTD Perera","year":"2023","unstructured":"Perera RMTD, Herath KHINM, Sanjeewa KKA, Jayawardena TU (2023) Recent reports on Bioactive compounds from Marine Cyanobacteria in Relation to Human Health Applications. Life 13(6):1411","journal-title":"Life"},{"key":"994_CR33","doi-asserted-by":"crossref","unstructured":"Udayan A, Pandey AK, Sirohi R, Sreekumar N, Sang BI, Sim SJ et al (2022) Production of microalgae with high lipid content and their potential as sources of nutraceuticals. Phytochem Rev 1\u201328","DOI":"10.1007\/s11101-021-09784-y"},{"issue":"4","key":"994_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11101-022-09848-7","volume":"22","author":"M Kaur","year":"2023","unstructured":"Kaur M, Bhatia S, Gupta U, Decker E, Tak Y, Bali M et al (2023) Microalgal bioactive metabolites as promising implements in nutraceuticals and pharmaceuticals: inspiring therapy for health benefits. Phytochem Rev 22(4):903\u2013933","journal-title":"Phytochem Rev"},{"issue":"2","key":"994_CR35","doi-asserted-by":"publisher","first-page":"e0118255","DOI":"10.1371\/journal.pone.0118255","volume":"10","author":"J Kumar","year":"2015","unstructured":"Kumar J, Dhar P, Tayade AB, Gupta D, Chaurasia OP, Upreti DK et al (2015) Chemical composition and biological activities of trans-himalayan alga Spirogyra porticalis (Muell.) Cleve. PLoS ONE 10(2):e0118255","journal-title":"PLoS ONE"},{"issue":"1","key":"994_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40529-024-00434-y","volume":"65","author":"SN Eladl","year":"2024","unstructured":"Eladl SN, Elnabawy AM, Eltanahy EG (2024) Recent biotechnological applications of value-added bioactive compounds from microalgae and seaweeds. Bot Stud 65(1):28","journal-title":"Bot Stud"},{"issue":"5","key":"994_CR37","first-page":"48","volume":"6","author":"E Eshetu","year":"2016","unstructured":"Eshetu E, Bassa AAT (2016) The Public Health significance of Leishmaniasis: an overview. J Nat Sci Res 6(5):48\u201357","journal-title":"J Nat Sci Res"},{"key":"994_CR38","unstructured":"Organization WH (2017) Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. World Health Organization, p 9240026436. Report No"},{"key":"994_CR39","unstructured":"Organization WH (2012) Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis. World Health Organization"},{"issue":"8","key":"994_CR40","doi-asserted-by":"publisher","first-page":"e525","DOI":"10.1016\/j.ijid.2011.03.021","volume":"15","author":"TS Tiuman","year":"2011","unstructured":"Tiuman TS, Santos AO, Ueda-Nakamura T, Dias Filho BP, Nakamura CV (2011) Recent advances in leishmaniasis treatment. Int J Infect Dis 15(8):e525\u2013e32","journal-title":"Int J Infect Dis"},{"issue":"3","key":"994_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","volume":"5","author":"P Minodier","year":"2007","unstructured":"Minodier P, Parola P (2007) Cutaneous leishmaniasis treatment. Travel Med Infect Dis 5(3):150\u2013158","journal-title":"Travel Med Infect Dis"},{"key":"994_CR42","doi-asserted-by":"publisher","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","volume":"104","author":"BM Roatt","year":"2020","unstructured":"Roatt BM, de Oliveira Cardoso JM, De Brito RCF, Coura-Vital W, de Aguiar-Soares O, Reis RD (2020) Recent advances and new strategies on leishmaniasis treatment. Appl Microbiol Biotechnol 104:8965\u20138977","journal-title":"Appl Microbiol Biotechnol"},{"key":"994_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","volume":"103","author":"DO Santos","year":"2008","unstructured":"Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB et al (2008) Leishmaniasis treatment\u2014a challenge that remains: a review. Parasitol Res 103:1\u201310","journal-title":"Parasitol Res"},{"issue":"4","key":"994_CR44","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/20477724.2020.1754655","volume":"114","author":"S Cortes","year":"2020","unstructured":"Cortes S, Bruno de Sousa C, Morais T, Lago J, Campino L (2020) Potential of the natural products against leishmaniasis in Old World-a review of in-vitro studies. Pathogens Global Health 114(4):170\u2013182","journal-title":"Pathogens Global Health"},{"issue":"10","key":"994_CR45","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.2174\/092986712799828300","volume":"19","author":"T Kobets","year":"2012","unstructured":"Kobets T, Grekov I, Lipoldova M (2012) Leishmaniasis: prevention, parasite detection and treatment. Curr Med Chem 19(10):1443\u20131474","journal-title":"Curr Med Chem"},{"key":"994_CR46","doi-asserted-by":"publisher","first-page":"105988","DOI":"10.1016\/j.actatropica.2021.105988","volume":"221","author":"CB Nieva","year":"2021","unstructured":"Nieva CB, Cid AG, Romero AI, Garc\u00eda-Bustos MF, Villegas M, Berm\u00fadez JM (2021) An appraisal of the scientific current situation and new perspectives in the treatment of cutaneous leishmaniasis. Acta Trop 221:105988","journal-title":"Acta Trop"},{"key":"994_CR47","doi-asserted-by":"publisher","first-page":"e00239","DOI":"10.1016\/j.parepi.2022.e00239","volume":"17","author":"Z Rashno","year":"2022","unstructured":"Rashno Z, Sharifi I, Oliaee RT, Tajbakhsh S, Sharififar F, Sharifi F et al (2022) Anti-leishmanial activity of Avicennia marina (Avicenniaceae family) leaves hydroalcoholic extract and its possible cellular mechanisms. Parasite Epidemiol Control 17:e00239","journal-title":"Parasite Epidemiol Control"},{"issue":"11","key":"994_CR48","doi-asserted-by":"publisher","first-page":"e14877","DOI":"10.1111\/jfpp.14877","volume":"44","author":"C Vasanthi","year":"2020","unstructured":"Vasanthi C, Appa Rao V, Narendra Babu R, Sriram P, Karunakaran R (2020) In-vitro antioxidant activities of aqueous and alcoholic extracts of Sargassum species\u2014Indian brown seaweed. J Food Process Preserv 44(11):e14877","journal-title":"J Food Process Preserv"},{"issue":"37","key":"994_CR49","first-page":"73","volume":"10","author":"N Sadati","year":"2011","unstructured":"Sadati N, Khanavi M, Mahrokh A, Nabavi S, Sohrabipour J, Hadjiakhoondi A (2011) Comparison of antioxidant activity and total phenolic contents of some Persian Gulf Marine algae. \u0641\u0635\u0644\u0646\u0627\u0645\u0647 \u0639\u0644\u0645\u06cc \u067e\u0698\u0648\u0647\u0634\u06cc \u06af\u06cc\u0627\u0647\u0627\u0646 \u062f\u0627\u0631\u0648\u06cc\u06cc 10(37):73\u201379","journal-title":"\u0641\u0635\u0644\u0646\u0627\u0645\u0647 \u0639\u0644\u0645\u06cc \u067e\u0698\u0648\u0647\u0634\u06cc \u06af\u06cc\u0627\u0647\u0627\u0646 \u062f\u0627\u0631\u0648\u06cc\u06cc"},{"key":"994_CR50","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10811-015-0538-0","volume":"28","author":"M-LF Lira","year":"2016","unstructured":"Lira M-LF, Lopes R, Gomes AP, Barcellos G, Ver\u00edcimo M, Osako K et al (2016) Anti-leishmanial activity of Brazilian green, brown, and red algae. J Appl Phycol 28:591\u2013598","journal-title":"J Appl Phycol"},{"issue":"3","key":"994_CR51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jep.2009.03.041","volume":"123","author":"V C\u00e9line","year":"2009","unstructured":"C\u00e9line V, Adriana P, Eric D, Joaquina AC, Yannick E, Augusto LF et al (2009) Medicinal plants from the Yanesha (Peru): evaluation of the leishmanicidal and antimalarial activity of selected extracts. J Ethnopharmacol 123(3):413\u2013422","journal-title":"J Ethnopharmacol"},{"key":"994_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00436-008-0970-z","volume":"103","author":"K Pontin","year":"2008","unstructured":"Pontin K, Da Silva Filho AA, Santos FF, Silva MLAe, Cunha WR, Nanayakkara ND et al (2008) In vitro and in vivo antileishmanial activities of a Brazilian green propolis extract. Parasitol Res 103:487\u2013492","journal-title":"Parasitol Res"},{"key":"994_CR53","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1590\/S0074-02762004000700017","volume":"99","author":"NM Lima","year":"2004","unstructured":"Lima NM, Correia CS, Leon LL, Machado G, Madeira MF, Santana AEG et al (2004) Antileishmanial activity of lapachol analogues. Mem Inst Oswaldo Cruz 99:757\u2013761","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-025-00994-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-025-00994-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-025-00994-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:20:54Z","timestamp":1741350054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-025-00994-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1007\/s11686-025-00994-4","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Shahid Sadoughi University of Medical Sciences, located in Yazd, Iran. The study was approved under the ethical code number IR.SSU.MEDICINE.REC.1403.93702. This clearance ensures that the research adheres to the ethical standards and guidelines set forth by the institution and relevant regulatory bodies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"51"}}